[HTML][HTML] The potential for mitochondrial therapeutics in the treatment of primary open-angle glaucoma: a review

G Kuang, M Halimitabrizi, AA Edziah, R Salowe… - Frontiers in …, 2023 - frontiersin.org
Glaucoma, an age-related neurodegenerative disease, is characterized by the death of
retinal ganglion cells (RGCs) and the corresponding loss of visual fields. This disease is the …

[HTML][HTML] The potential for mitochondrial therapeutics in the treatment of primary open-angle glaucoma: a review

G Kuang, M Halimitabrizi, AA Edziah… - Frontiers in …, 2023 - ncbi.nlm.nih.gov
Glaucoma, an age-related neurodegenerative disease, is characterized by the death of
retinal ganglion cells (RGCs) and the corresponding loss of visual fields. This disease is the …

The potential for mitochondrial therapeutics in the treatment of primary open-angle glaucoma: a review

G Kuang, M Halimitabrizi, AA Edziah… - Frontiers in …, 2023 - pubmed.ncbi.nlm.nih.gov
Glaucoma, an age-related neurodegenerative disease, is characterized by the death of
retinal ganglion cells (RGCs) and the corresponding loss of visual fields. This disease is the …

The potential for mitochondrial therapeutics in the treatment of primary open-angle glaucoma: a review

G Kuang, M Halimitabrizi, A Edziah, R Salowe… - Frontiers in …, 2023 - europepmc.org
Glaucoma, an age-related neurodegenerative disease, is characterized by the death of
retinal ganglion cells (RGCs) and the corresponding loss of visual fields. This disease is the …

The potential for mitochondrial therapeutics in the treatment of primary open-angle glaucoma: a review.

G Kuang, M Halimitabrizi, AA Edziah… - Frontiers in …, 2023 - europepmc.org
Glaucoma, an age-related neurodegenerative disease, is characterized by the death of
retinal ganglion cells (RGCs) and the corresponding loss of visual fields. This disease is the …